International Clinical Trial: A Study in Young People and Adults to Learn About the Medicine Ritlecitinib for Treatment of Patchy Hair Loss, Known by the Medical Term as Moderate Alopecia Areata

Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07733765) titled 'A Study in Young People and Adults to Learn About the Medicine Ritlecitinib for Treatment of Patchy Hair Loss, Known by the Medical Term as Moderate Alopecia Areata' on July 24.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).

Primary Sponsor: Pfizer

Condition: Alopecia Areata

Intervention: Drug: Ritlecitinib 100 mg Drug: Ritlecitinib 50 mg

Recruitment Status: Not recruiting

Phase: Phase 3

Date of First Enrollment: July 31, 2026

Target Sampl...